Answers are grounded in this paper and cite their sources.
Demonstrates improved scaffold generation for inhibitors in medicinal chemistry, suggesting enhanced lead development.
Designing novel core scaffolds for small molecules is an important yet challenging task in medicinal chemistry, particularly during the lead‐generation stage and in situations that require alternative chemotypes and/or chemical novelty. In this study, we applied an artificial intelligence‐based structure generation using the DeepSARM methodology to create novel scaffold series and to augment medicinal chemistry capabilities. Samotolisib, a PI3K/mTOR dual inhibitor featuring a tricyclic scaffold, was selected as a model ligand. Following DeepSARM‐guided structure generation and ligand‐based virtual screening, several candidate compounds with simplified scaffolds were identified. Notably, one top‐ranked virtual hit 6 was selected and further optimized into a simplified tool compound 6A for experimental validation. Subsequent synthesis and in vitro evaluation led to the identification of a validated hit bearing a novel nontricyclic scaffold.
No takes yet. Share an insight, caveat, or question.
Shimokawa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: